Where Will Viatris Be in 5 Years? | The Motley Fool
Can this become a good growth business to invest in?
Source: fool.com
Stay updated with breaking news from Famy Life. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Can this become a good growth business to invest in?
These pharmaceutical companies are profitable and offer above-average dividends.
Two years after the close of the merger that formed Viatris, the company is acquiring Oyster Point Pharma and Famy Life Sciences to expand its scope in ophthalmology, one of three therapeutic areas it is now focusing on for revenue growth.
These are the stocks posting the largest moves midday.
These are the stocks posting the largest moves midday.